Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) Return on assets
Hinge Health Inc.'s return on assets over the twelve months to 30 June 2026 was 14.1%, up 73.9 percentage points from fiscal 2025 (−59.8%). That is above the Health Information Services industry median of −5.62% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −59.8% | (57.97) |
| FY2024 | −1.84% | (1.84) |
| FY2023 | 0.00% | — |
Return on assets against peers
| Company | Return on assets |
|---|---|
| HNGE Hinge Health Inc. | 14.1% |
| DOCS Doximity, Inc. compare | 11.9% |
| HQY HealthEquity, Inc. compare | 7.07% |
| BTSG BrightSpring Health Services, Inc. compare | 6.66% |
| WAY Waystar Holding Corp. compare | 2.53% |
| PRVA Privia Health Group, Inc. compare | 2.38% |
| TEM Tempus AI, Inc. compare | −8.00% |
| SDGR Schrodinger, Inc. compare | −9.36% |
| HTFL Heartflow, Inc. compare | −47.0% |
| Health Information Services industry median | −5.62% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on HNGE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement